Anita Gupta

At the time, the FDA presented a lot of adverse event data that showed there was a risk of immunogenicity — immune reactions — and that raised some red flags for the committee,

• said Gupta, an adjunct assistant professor of anesthesiology at the Johns Hopkins University School of Medicine
  NBC Newsnbcnews.com/health/health…Jun 30, 19:36

Studies have begun to show that there are significant issues with some of these products. Some of them have heavy metals. Some have microbial contamination. Some are mislabeled,

• Gupta said
  NBC Newsnbcnews.com/health/health…Jun 30, 19:36